CINXE.COM

<!DOCTYPE html> <html lang="en"> <head> <meta charset="utf-8"> <title>🇰🇷 Case study on the Occurrence of Impurities in Pharmaceuticals (Focusing on NDMA Cases) - Guidance, Documents, Resources - Nitrosamines Exchange</title> <meta name="description" content="Authored by Korean NIFDS This case study collection focuses on NDMA cases to identify risk factors and evaluate the potential for impurity generation in each stage. It presents several cases related to this and suggests&hellip;"> <meta name="generator" content="Discourse 3.3.2 - https://github.com/discourse/discourse version c5f9a300d8ef7ad6e65b49705969c4bab231dc04"> <link rel="icon" type="image/png" href="https://nitrosamines.usp.org/uploads/db7259/optimized/1X/b9906df5ca25f2971af41d68e4430d26e5350374_2_32x32.png"> <link rel="apple-touch-icon" type="image/png" href="https://nitrosamines.usp.org/uploads/db7259/optimized/1X/3a4527a1afa6ecba86c36a386cb333201a8f1124_2_180x180.jpeg"> <meta name="theme-color" media="(prefers-color-scheme: light)" content="#f8f9fa"> <meta name="theme-color" media="(prefers-color-scheme: dark)" content="#f8f9fa"> <meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, user-scalable=yes, viewport-fit=cover"> <link rel="canonical" href="https://nitrosamines.usp.org/t/case-study-on-the-occurrence-of-impurities-in-pharmaceuticals-focusing-on-ndma-cases/10142" /> <link rel="search" type="application/opensearchdescription+xml" href="https://nitrosamines.usp.org/opensearch.xml" title="Nitrosamines Exchange Search"> <link href="/stylesheets/color_definitions_usp-light_18_41_b1033ae00cf16116a0152a326f7de3cb754db176.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" class="light-scheme"/><link href="/stylesheets/color_definitions_usp-light_18_41_b1033ae00cf16116a0152a326f7de3cb754db176.css?__ws=nitrosamines.usp.org" media="(prefers-color-scheme: dark)" rel="stylesheet" class="dark-scheme"/> <link href="/stylesheets/desktop_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop" /> <link href="/stylesheets/chat_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="chat" /> <link href="/stylesheets/checklist_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="checklist" /> <link href="/stylesheets/discourse-adplugin_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-adplugin" /> <link href="/stylesheets/discourse-cakeday_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-cakeday" /> <link href="/stylesheets/discourse-calendar_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-calendar" /> <link href="/stylesheets/discourse-data-explorer_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-data-explorer" /> <link href="/stylesheets/discourse-details_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-details" /> <link href="/stylesheets/discourse-docs_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-docs" /> <link href="/stylesheets/discourse-lazy-videos_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-lazy-videos" /> <link href="/stylesheets/discourse-local-dates_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-local-dates" /> <link href="/stylesheets/discourse-narrative-bot_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-narrative-bot" /> <link href="/stylesheets/discourse-presence_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-presence" /> <link href="/stylesheets/discourse-solved_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-solved" /> <link href="/stylesheets/discourse-topic-voting_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-topic-voting" /> <link href="/stylesheets/discourse-translator_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-translator" /> <link href="/stylesheets/footnote_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="footnote" /> <link href="/stylesheets/poll_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="poll" /> <link href="/stylesheets/spoiler-alert_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="spoiler-alert" /> <link href="/stylesheets/z-communiteq-features_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="z-communiteq-features" /> <link href="/stylesheets/chat_desktop_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="chat_desktop" /> <link href="/stylesheets/discourse-calendar_desktop_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-calendar_desktop" /> <link href="/stylesheets/discourse-topic-voting_desktop_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="discourse-topic-voting_desktop" /> <link href="/stylesheets/poll_desktop_130a13458e189b6f6fe61bec489f29082d7aeb4b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="poll_desktop" /> <link href="/stylesheets/desktop_theme_42_d7c5e06d2e6c33f768716f78bd5b7dcfa093cb89.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="42" data-theme-name="category banners"/> <link href="/stylesheets/desktop_theme_10_36332c8319178e968ea562353739a17cb3e98b38.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="10" data-theme-name="discourse avatar component"/> <link href="/stylesheets/desktop_theme_27_d1258257cba3479e81f9aee4768f6cc406a7a5e9.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="27" data-theme-name="discourse clickable topic"/> <link href="/stylesheets/desktop_theme_28_1a59c3a10f62ea1ba8f7f98853516f34462a657c.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="28" data-theme-name="easy footer"/> <link href="/stylesheets/desktop_theme_56_3c7d2e137ce4d24b07fe44e20cce4a2d381dcb34.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="56" data-theme-name="featured links"/> <link href="/stylesheets/desktop_theme_57_6f12f3ae0dcb8a39e3c5cb85fe13acf149cc56a4.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="57" data-theme-name="featured topics"/> <link href="/stylesheets/desktop_theme_51_e95a76febaf1e6d3ab3abf3495dbac0cf713d110.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="51" data-theme-name="header locale selector"/> <link href="/stylesheets/desktop_theme_30_f4c2c108d00d9f452a08b28538caad53bc153e58.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="30" data-theme-name="modern category + group boxes"/> <link href="/stylesheets/desktop_theme_50_9f9673b09d0b47154269f19383283b953ae25320.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="50" data-theme-name="navigation menu display control"/> <link href="/stylesheets/desktop_theme_54_dc60a6a05175148b9021a82ca112ee8033fcc1a1.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="54" data-theme-name="primary button"/> <link href="/stylesheets/desktop_theme_55_0408901a4c360fde1863e6e3e235eadba5c18045.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="55" data-theme-name="rounded"/> <link href="/stylesheets/desktop_theme_43_b5df2dad78acaf6af14dedea458c3f60bb1da19b.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="43" data-theme-name="tag banners"/> <link href="/stylesheets/desktop_theme_9_afd515ef291dac2ff60a92d8e15ad7c568bb034e.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="9" data-theme-name="trust level avatar flair"/> <link href="/stylesheets/desktop_theme_41_5a70a03a0dca887672acbb291656c7f48eea1a93.css?__ws=nitrosamines.usp.org" media="all" rel="stylesheet" data-target="desktop_theme" data-theme-id="41" data-theme-name="usp experts"/> <script defer="" src="/theme-javascripts/c5245b44108ad7226a95529563bb5884437c498d.js?__ws=nitrosamines.usp.org" data-theme-id="9" nonce="Z2ihhkrerAxu6THpuAqtEk68O"></script>    <div id="ZN_b3MMRaiYHsiCyuG"></div> <script defer="" src="/theme-javascripts/e69152c40c9991a941252686e47cd27ddcadba64.js?__ws=nitrosamines.usp.org" data-theme-id="37" nonce="Z2ihhkrerAxu6THpuAqtEk68O"></script>  <script async="" src="https://www.googletagmanager.com/gtag/js?id=G-GZCGZQZ1K4" nonce="Z2ihhkrerAxu6THpuAqtEk68O"></script> <script defer="" src="/theme-javascripts/65f877b3703b22bd928363eb6bbf81ca4ea05778.js?__ws=nitrosamines.usp.org" data-theme-id="37" nonce="Z2ihhkrerAxu6THpuAqtEk68O"></script> <meta id="data-ga-universal-analytics" data-tracking-code="G-GZCGZQZ1K4" data-json="{"cookieDomain":"auto"}" data-auto-link-domains=""> <script defer src="/assets/google-universal-analytics-v3-08add7ec997ab472fcd9f821d32ff7caf4b8b9a5de2ec18ca723a040be07a098.js" data-discourse-entrypoint="google-universal-analytics-v3" nonce="Z2ihhkrerAxu6THpuAqtEk68O"></script> <link rel="alternate nofollow" type="application/rss+xml" title="RSS feed of '🇰🇷 Case study on the Occurrence of Impurities in Pharmaceuticals (Focusing on NDMA Cases)'" href="https://nitrosamines.usp.org/t/case-study-on-the-occurrence-of-impurities-in-pharmaceuticals-focusing-on-ndma-cases/10142.rss" /> <meta property="og:site_name" content="Nitrosamines Exchange" /> <meta property="og:type" content="website" /> <meta name="twitter:card" content="summary" /> <meta property="og:image" content="https://nitrosamines.usp.org/uploads/db7259/original/1X/245b8254540e755a018d20f2ffa64946d05afb63.svg" /> <meta property="og:url" content="https://nitrosamines.usp.org/t/case-study-on-the-occurrence-of-impurities-in-pharmaceuticals-focusing-on-ndma-cases/10142" /> <meta name="twitter:url" content="https://nitrosamines.usp.org/t/case-study-on-the-occurrence-of-impurities-in-pharmaceuticals-focusing-on-ndma-cases/10142" /> <meta property="og:title" content="🇰🇷 Case study on the Occurrence of Impurities in Pharmaceuticals (Focusing on NDMA Cases)" /> <meta name="twitter:title" content="🇰🇷 Case study on the Occurrence of Impurities in Pharmaceuticals (Focusing on NDMA Cases)" /> <meta property="og:description" content="Authored by Korean NIFDS This case study collection focuses on NDMA cases to identify risk factors and evaluate the potential for impurity generation in each stage. It presents several cases related to this and suggests specific evaluation methods. It is expected that this case study collection will be helpful in product development design of pharmaceuticals which can produce nitrosamine impurities. This document provides examples of identifying risk factors and evaluating the causes of nitros..." /> <meta name="twitter:description" content="Authored by Korean NIFDS This case study collection focuses on NDMA cases to identify risk factors and evaluate the potential for impurity generation in each stage. It presents several cases related to this and suggests specific evaluation methods. It is expected that this case study collection will be helpful in product development design of pharmaceuticals which can produce nitrosamine impurities. This document provides examples of identifying risk factors and evaluating the causes of nitros..." /> <meta property="og:article:section" content="Guidance, Documents, Resources" /> <meta property="og:article:section:color" content="0088CC" /> <meta property="og:article:tag" content="risk-assessment" /> <meta name="twitter:label1" value="Reading time" /> <meta name="twitter:data1" value="1 mins 🕑" /> <meta name="twitter:label2" value="Likes" /> <meta name="twitter:data2" value="3 ❤" /> <meta property="article:published_time" content="2024-05-31T16:36:37+00:00" /> <meta property="og:ignore_canonical" content="true" /> </head> <body class="crawler browser-update"> <header> <a href="/"> Nitrosamines Exchange </a> </header> <div id="main-outlet" class="wrap" role="main"> <div id="topic-title"> <h1> <a href="/t/case-study-on-the-occurrence-of-impurities-in-pharmaceuticals-focusing-on-ndma-cases/10142">🇰🇷 Case study on the Occurrence of Impurities in Pharmaceuticals (Focusing on NDMA Cases)</a> </h1> <div class="topic-category" itemscope itemtype="http://schema.org/BreadcrumbList"> <span itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a href="/c/guidance-documents-resources/20" class="badge-wrapper bullet" itemprop="item"> <span class='badge-category-bg' style='background-color: #0088CC'></span> <span class='badge-category clear-badge'> <span class='category-name' itemprop='name'>Guidance, Documents, Resources</span> </span> </a> <meta itemprop="position" content="1" /> </span> </div> <div class="topic-category"> <div class='discourse-tags list-tags'> <a href='https://nitrosamines.usp.org/tag/risk-assessment' class='discourse-tag' rel="tag">risk-assessment</a> </div> </div> </div> <div itemscope itemtype='http://schema.org/DiscussionForumPosting'> <meta itemprop='headline' content='🇰🇷 Case study on the Occurrence of Impurities in Pharmaceuticals (Focusing on NDMA Cases)'> <link itemprop='url' href='https://nitrosamines.usp.org/t/case-study-on-the-occurrence-of-impurities-in-pharmaceuticals-focusing-on-ndma-cases/10142'> <meta itemprop='datePublished' content='2024-05-31T16:36:37Z'> <meta itemprop='articleSection' content='Guidance, Documents, Resources'> <meta itemprop='keywords' content='risk-assessment'> <div itemprop='publisher' itemscope itemtype="http://schema.org/Organization"> <meta itemprop='name' content='United State Pharmacopeia'> <div itemprop='logo' itemscope itemtype="http://schema.org/ImageObject"> <meta itemprop='url' content='https://nitrosamines.usp.org/uploads/db7259/original/1X/245b8254540e755a018d20f2ffa64946d05afb63.svg'> </div> </div> <div id='post_1' class='topic-body crawler-post'> <div class='crawler-post-meta'> <span class="creator" itemprop="author" itemscope itemtype="http://schema.org/Person"> <a itemprop="url" href='https://nitrosamines.usp.org/u/Naiffer_Host'><span itemprop='name'>Naiffer_Host</span></a> </span> <link itemprop="mainEntityOfPage" href="https://nitrosamines.usp.org/t/case-study-on-the-occurrence-of-impurities-in-pharmaceuticals-focusing-on-ndma-cases/10142"> <span class="crawler-post-infos"> <time datetime='2024-05-31T16:36:37Z' class='post-time'> May 31, 2024, 4:36pm </time> <meta itemprop='dateModified' content='2024-05-31T16:36:37Z'> <span itemprop='position'>1</span> </span> </div> <div class='post' itemprop='text'> <p>Authored by Korean NIFDS</p> <p>This case study collection focuses on NDMA cases to identify risk factors and evaluate the potential for impurity generation in each stage. It presents several cases related to this and suggests specific evaluation methods. It is expected that this case study collection will be helpful in product development design of pharmaceuticals which can produce nitrosamine impurities.</p> <p>This document provides examples of identifying risk factors and evaluating the causes of nitrosamine impurity generation, such as NDMA, during the pharmaceutical manufacturing process. In the synthesis stage, the conditions such as synthesis process, solvent, reagent, reaction temperature, pH, etc., which are the main causes of nitrosamine impurities for valsartan drugs, were comprehensively summarized and described with a focus on cases where major amines were analyzed. In the formulation stage, a study was conducted to identify the causes of impurity generation using experimental design methods, focusing on metformin drugs and various causes such as heat, moisture, and excipients. A recently published literature review has shown that the wet granulation process, which introduces heat and moisture, is an important step in NDMA generation. Finally, for the storage stage, the study presents results on the tendency of NDMA generation during storage of nizatidine drugs and the prediction of the rate and reaction constant using temperature and humidity.</p> <p>The contents are as follows:</p> <p>I. Overview</p> <p>II. Nitrosamine Generation Mechanism (General Conditions)</p> <p>III. Considerations During the Manufacturing Process</p> <ol> <li>Synthesis Stage</li> <li>Formulation Stage</li> <li>Packaging Stage</li> </ol> <p>IV. Synthesis Stage: Evaluation of NDMA Occurrence in Valsartan Synthesis</p> <ol> <li>Potential for NDMA Generation in Sartan Synthesis</li> <li>Examples of Nitrosamine Generation During Synthesis</li> <li>Analysis of NDMA Generation Potential</li> </ol> <p>V. Formulation Stage: Evaluation of NDMA Occurrence in Metformin Formulation</p> <ol> <li>Potential for NDMA Generation in Metformin Formulation</li> <li>Analysis of NDMA Generation Potential</li> </ol> <p>VI. Storage Stage: Evaluation of NDMA Occurrence in Nizatidine Storage</p> <ol> <li>Potential for NDMA Generation in Nizatidine Storage</li> <li>Analysis of NDMA Generation Potential</li> </ol> <p>VII. Discussion</p> <p>English Version (AI translated)<br> <a class="attachment" href="/uploads/short-url/yeBCWE3FmnInve0VrDHuF0GNq04.pdf">Machine Translated Document - IDRAC 384600 (1).pdf</a> (9.4 MB)</p> <p>Original Koren Version:<br> <a class="attachment" href="/uploads/short-url/t2bVrijKVNHu9Zq9rDZAqssuzZi.pdf">IDRAC_384600_31-May-2024_NIFDS Guide-11-1471057-000667-01_ Case study on the Occurrence of Impuritie.pdf</a> (2.3 MB)</p> </div> <div itemprop="interactionStatistic" itemscope itemtype="http://schema.org/InteractionCounter"> <meta itemprop="interactionType" content="http://schema.org/LikeAction"/> <meta itemprop="userInteractionCount" content="3" /> <span class='post-likes'>3 Likes</span> </div> </div> </div> </div> <footer class="container wrap"> <nav class='crawler-nav'> <ul> <li itemscope itemtype='http://schema.org/SiteNavigationElement'> <span itemprop='name'> <a href='/' itemprop="url">Home </a> </span> </li> <li itemscope itemtype='http://schema.org/SiteNavigationElement'> <span itemprop='name'> <a href='/categories' itemprop="url">Categories </a> </span> </li> <li itemscope itemtype='http://schema.org/SiteNavigationElement'> <span itemprop='name'> <a href='/guidelines' itemprop="url">Guidelines </a> </span> </li> <li itemscope itemtype='http://schema.org/SiteNavigationElement'> <span itemprop='name'> <a href='/tos' itemprop="url">Terms of Service </a> </span> </li> <li itemscope itemtype='http://schema.org/SiteNavigationElement'> <span itemprop='name'> <a href='/privacy' itemprop="url">Privacy Policy </a> </span> </li> </ul> </nav> <p class='powered-by-link'>Powered by <a href="https://www.discourse.org">Discourse</a>, best viewed with JavaScript enabled</p> </footer>  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-M9F65K3" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>  <div class="buorg"><div>Unfortunately, <a href="https://www.discourse.org/faq/#browser">your browser is unsupported</a>. Please <a href="https://browsehappy.com">switch to a supported browser</a> to view rich content, log in and reply.</div></div> </body> </html>